Trial Profile
The effectiveness and safety of lobaplatin or cisplatin combined with etoposide for advanced small cell lung cancer: a prospective, dynamic randomized, positive controlled, multi-center clinical trial.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Etoposide (Primary) ; Lobaplatin (Primary) ; Cisplatin
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2010 New trial record